Maternal Diabetes Mellitus is Associated with Altered Deposition of Fibrin-type Fibrinoid at the Villous Surface in Term Placentae

scientific article published on 01 May 2003

Maternal Diabetes Mellitus is Associated with Altered Deposition of Fibrin-type Fibrinoid at the Villous Surface in Term Placentae is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1053/PLAC.2002.0953
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0143400402909537?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0143400402909537?httpAccept=text/xml
P698PubMed publication ID12744929

P2093author name stringT. M. Mayhew
C. Sampson
P2860cites workPregnancy complicating diabetesQ28284159
Denudations as paracellular routes for alphafetoprotein and creatinine across the human syncytiotrophoblastQ30845427
Diabetes epidemiology as a tool to trigger diabetes research and careQ33638290
Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndromeQ33916231
The volumetric composition of human term placentae: altitudinal, ethnic and sex differences in BoliviaQ34090739
Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblastsQ34123183
Pathophysiology of oxidative stress in diabetes mellitusQ34310277
Villous trophoblast of human placenta: a coherent view of its turnover, repair and contributions to villous development and maturationQ34408495
Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placentaQ35811891
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort studyQ36245629
Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblastQ36830490
Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitusQ37066210
The fibrinolytic system in diabetes mellitusQ37124843
Inhibitors of fibrinolysis in diabetic children, mothers, and their newbornQ39593992
Nonenzymatic Glycosylation Reduces the Susceptibility of Fibrin to Degradation by PlasminQ72787738
Quantitative aspects of placental structureQ72858440
Stereological comparison of 3D spatial relationships involving villi and intervillous pores in human placentas from control and diabetic pregnanciesQ73003843
Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiationQ73880666
A stereological method for testing whether or not there is random deposition of perivillous fibrin-type fibrinoid at the villous surface: description and pilot applications to term placentaeQ74312106
Immuno-electron microscopic localization of endothelial nitric oxide synthase in human placental terminal villous trophoblasts-normal and pre-eclamptic pregnancyQ74612817
Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cellsQ77481508
Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestationQ77763602
Etiology and pathophysiology of gestational diabetes mellitusQ39820414
The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperiumQ40103726
Diabetes as an atherogenic factor.Q40176087
Villous trophoblast: morphometric perspectives on growth, differentiation, turnover and deposition of fibrin-type fibrinoid during gestationQ40691558
Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospectsQ40795448
Some chemical indices of diabetic vascular diseaseQ41244222
The fibrinoids of the human placenta: origin, composition and functional relevance.Q41331763
Is there a physiological intravascular coagulation in obstetrical cases?Q41433730
Histomorphometry of the human placenta in Class C diabetes mellitusQ41497669
Fibrinogen and diabetes mellitus: is it time for intervention trials?Q41531053
The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme functionQ41719101
Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placentaQ42462623
Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.Q42472477
Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria.Q44012882
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusQ44553205
Reassessment of White's classification and Pedersen's prognostically bad signs of diabetic pregnancies in insulin-dependent diabetic pregnanciesQ44669634
Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancyQ47176184
Quantitative studies on the villi, trophoblast and intervillous pores of placentae from women with well-controlled diabetes mellitusQ47702644
BCL-2 expression in the human placenta and its correlation with fibrin depositsQ47750468
Quantitative studies of human placenta. I. MorphometryQ47926050
Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli.Q47930335
The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.Q51599447
Fibrin generation during the diabetic pregnancy.Q51644147
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.Q53751216
Hypobaric hypoxia and villous trophoblast: evidence that human pregnancy at high altitude (3600 m) perturbs epithelial turnover and coagulation-fibrinolysis in the intervillous spaceQ57110911
Impaired fibrinolytic response to exercise in type II diabetes: Effects of exercise and physical trainingQ58108521
Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sitesQ59663108
Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnanciesQ61929887
Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetesQ61971143
Plasma Cofactors of Platelet Function: Correlation with Diabetic Retinopathy and Hemoglobins Ala-cQ66876851
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetesQ67574961
Relationship of microvascular disease in diabetes to metabolic controlQ67599756
Thrombin clottable determination of plasma fibrinogen in pregnancyQ67750821
Blood coagulation and fibrinolysis during normal pregnancyQ67990317
Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitusQ68354986
Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after deliveryQ68530681
Fibrinolysis and plasminogen levels in pregnancy and the puerperiumQ70059653
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-VQ70220095
Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patientsQ70803654
Histomorphometry of the placenta of the diabetic woman: Class A diabetes mellitusQ70922443
The fluid phase of coagulation and the accelerated atherosclerosis of diabetes mellitusQ70973565
Coagulation and fibrinolysis in smoking and nonsmoking pregnant womenQ71406668
Quantitative structure of the normal human placenta from 10 weeks of gestation to termQ71426121
Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitusQ71524902
Immunohistochemistry of two different types of placental fibrinoidQ71658998
Histomorphometry of the human placenta in Class B diabetes mellitusQ71749132
Perivillous fibrin deposition in the human placentaQ72217304
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortionQ72361563
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulationQ72416328
Growth and maturation of villi in placentae from well-controlled diabetic womenQ72530284
Oxygen diffusive conductance in placentae from control and diabetic womenQ72616700
Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysisQ72736003
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)524-531
P577publication date2003-05-01
P1433published inPlacentaQ7200288
P1476titleMaternal diabetes mellitus is associated with altered deposition of fibrin-type fibrinoid at the villous surface in term placentae
Maternal Diabetes Mellitus is Associated with Altered Deposition of Fibrin-type Fibrinoid at the Villous Surface in Term Placentae
P478volume24

Reverse relations

cites work (P2860)
Q80676339Distribution of the glycoconjugate oligosaccharides in the human placenta from pregnancies complicated by altered glycemia: lectin histochemistry
Q38603046Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.
Q92164555Platelet-derived factors impair placental chorionic gonadotropin beta-subunit synthesis
Q80031211Stereological analysis of mature human placenta of pregnant women of different age

Search more.